Notice of Intent to Sole Source � George Washington University
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH - CC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 26-008606 in this department, oldest first.
- Aug 27, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
The purpose of this action is to increase epidemiologist hours to the existing contract 75N98026P01031 with George Washington University to address increased workload requirements identified during the first project year at the National Institutes of Health (NIH) Clinical Center (CC). � Product Service Code: AJ52 - General Science/Technology: Life Sciences (Applied Research/Exploratory Development) � NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) � Place of Performance: Bethesda, MD 20892 USA POTS: 26-0086… (show all)
06 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to George Washington University, located at 1918 F St. NW, Washington DC, on a firm fixed price sole source award basis to provide epidemiologist services to the National Institutes of Health. This action requests approval to add additional epidemiologist hours to the contract to address increased workload requirements identified during the first project year. The originally budgeted level of effort for epidemiological planning activities has proven insufficient to meet project needs. Key planning functions�including study design, protocol development, and analytic framework formulation�have required substantially more time than anticipated to ensure scientific rigor and compliance with all applicable grant requirements. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by September 3rd, 2026 at 3pm EST.
Who won similar work
58 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same NAICS 541715.
Single-winner award sizes (45): middle half $4.9M to $35.0M, median $17.1M; range $10K to $79.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| DUKE UNIVERSITY Durham NC 27705 USA | 2 | $36.3M | Mar 31, 2025 |
| The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA | 2 | $17.1M + 1 shared | Sep 25, 2026 |
| Northwestern University 750 N. LAKE SHORE DRIVE RUBLOFF 7TH FLOOR CHICAGO IL 60611 USA | 2 | $7.7M + 1 shared | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD. Winston Salem NC 27157 USA | 2 | $4.9M + 1 shared | Apr 10, 2025 |
| SCIOME LLC | 1 | $79.3M | Aug 27, 2026 |
| UNIVERSITY OF MISSISSIPPI MEDICAL CENTER Jackson MS 39216 USA | 1 | $63.9M | Sep 15, 2025 |
| TEMPUS AI, INC · $TEM · $531.8M | 1 | $60.6M | Sep 17, 2025 |
| UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVENUE NE BOX 359472 Seattle WA 98195 USA | 1 | $55.5M | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES Winston Salem NC 27157 USA | 1 | $49.5M | Sep 15, 2025 |
| FISHER BIOSERVICES INC | 1 | $48.0M | Oct 7, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TEM reported $531.8M revenue in FY2025. The median single-winner award in these 45 past awards, $17.1M, is 3% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESMateriality: 0.11% of $TMO revenue (Low) SEC
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 28, 2026Versiti Blood Health, Inc.$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 25, 2026WESTAT, INC.$21.4MA--REDS-V-Data Coordinating CenterNo listed company matched (Materiality N/A)
- Sep 25, 2026The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 21 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.